BOYCE, CHRISTOPHER W.,DEGRADO, SYLVIA JOANNA,CHEN, XIAO,QIN, JUN,MAZZOLA, ROBERT D., JR.,YU, YOUNONG,MCCORMICK, KEVIN D.,PALANI, ANANDAN,XIAO, DONG,ASLANIAN, ROBERT GEORGE,WU, JIE,RAO, ASHWIN UMESH,SI
申请号：
CA2818597
公开号：
CA2818597A1
申请日:
2011.12.19
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The invention provides certain quinoxalines and aza-quinoxalines of the Formula (I), and their pharmaceutically acceptable salts, wherein J1, J2, R1, R2, R3, R22, Ra, Rb, Rc, Rd, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with with uncontrolled or inappropriate stimulation of CRTH2 function.
